CBE ID
0586
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description
This measure identifies the percentage of patients taking warfarin during the measurement year who had at least one PT/INR test within 30 days after the first warfarin prescription in the measurement year
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Patients in the denominator who had a PT/INR test within 30 days after the first warfarin claim during the measurement year
Time Window: See belowDenominatorPatients who are taking warfarin during the measurement year
Time Window: See belowExclusionsClaims from the hospital or ER from the warfarin start date to warfarin start date + 30 days
Testing Data Sources
- Measure StructureNon Condition SpecificTarget PopulationNational Quality Strategy PrioritiesPatient Safety
- Risk Adjustment
- Current or planned use(s)
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Patient Safety Project 2013-2014Initial EndorsementEndorsement StatusLast UpdatedRemoval Date
- StewardSteward Organization Email